Table 3. Comparison of parameters between test group and control group after the 2-year lifestyle intervention.
| Parameter | Control group | Test group | P value |
|---|---|---|---|
| (n = 130) | (n = 130) | ||
| Weight (kg) | 75.97 ± 11.01 | 75.34 ± 9.94 | 0.627 |
| SBP (mmHg) | 120.38 ± 12.84 | 120.40 ± 13.70 | 0.993 |
| DBP (mmHg) | 78.99 ± 9.41 | 78.55 ± 11.70 | 0.735 |
| FLI | 52.06 ± 24.38 | 44.72 ± 23.08 | 0.013 |
| NAFLD Fibrosis Score | −28.85 ± 2.12 | −28.87 ± 2.27 | 0.939 |
| Liver Dysfunction | |||
| ALT (U/L) | 28.78 ± 20.88 | 23.95 ± 12.50 | 0.025 |
| AST (U/L) | 23.56 ± 13.18 | 21.12 ± 6.90 | 0.063 |
| GGT (mmol/L) | 40.56 ± 32.88 | 33.96 ± 30.39 | 0.094 |
| Lipid profile | |||
| TCH (mmol/L) | 4.86 ± 0.88 | 4.84 ± 0.82 | 0.878 |
| LDL-C (mmol/L) | 2.85 ± 0.67 | 2.92 ± 0.68 | 0.450 |
| HDL-C (mmol/L) | 1.23 ± 0.23 | 1.27 ± 0.26 | 0.193 |
| TG (mmol/L) | 2.07 ± 1.48 | 1.71 ± 0.93 | 0.022 |
| Insulin resistance | |||
| FPG (mmol/L) | 5.03 ± 1.29 | 5.02 ± 1.08 | 0.988 |
| Liver Steatosis grade | |||
| Grade 0 n (%) | 9 (6.9%) | 41 (31.5%) | <0.001 |
| Grade 1 n (%) | 59 (45.4%) | 69 (53.1%) | |
| Grade 2 n (%) | 9 (6.9%) | 12 (9.2%) | |
| Grade 3 n (%) | 53 (40.8%) | 8 (6.2%) | |
FLI = fatty liver index, NAFLD-FS = NAFLD-fibrosis score, BMI = body mass index, SBP = systolic blood pressure, DBP = diastolic blood pressure, ALT = alanine aminotransferase, AST = aspartate aminotransferase, GGT = gamma-glutamine transpeptidase, TCH = total cholesterol, TG = triglyceride, LDL-C = low-density lipoprotein cholesterol, HDL-C = high-density lipoprotein cholesterol, FPG = fasting plasma glucose.